A unique delivery process could mean faster, cheaper and more effective vaccination procedures.
A unique delivery process could mean faster, cheaper and more effective vaccination procedures. Instead of using the disease organism itself, which all conventional vaccines rely on, the new technology uses bacterial viruses called 'bacteriophage' that contain DNA. The DNA vaccine is placed inside the bacteriophage with special instructions so that the vaccinated host can make the vaccine by reading the DNA.
Big DNA Ltd, a spin out company from the Moredun Research Institute in Edinburgh (UK), has been created to develop and commercialize the technology. Dr John March, creator of the company, says: "We couldn't have taken the development of this process further, without spinning out the technology, patents and processes from the research establishment and creating Big DNA Ltd as a commercial firm to do it. The potential here is enormous and I am passionate about getting this process to become a reality."
Bacteriophage have many advantages. Conventional vaccines are difficult and expensive to make, require specialist facilities and expertise, and sometimes fail to work for certain diseases. Bacteriophage cannot cause the disease they are immunizing against and can also be taken orally, either in liquid or tablet form, eliminating the need for needles and injections, and all their associated hazards.
March concludes: "This cheap and effective way of developing and delivering vaccines has enormous importance for public health in the future."
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.